Physician profile
David Lawrence Smith
NPI 1154355626
$2,011.06
in general payments reported to CMS, 2019-2025
15 companies · $85.31 in 2025
The $85.31 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $13.24 · 2021: $38.67 · 2022: $944 · 2023: $181 · 2024: $390 · 2025: $85.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.46 |
| Education | $108.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $784.92 | 2022-2023 | Da Vinci Surgical System |
| Abiomed | $271.53 | 2024 | Impella |
| Ethicon US, LLC | $254.90 | 2019-2024 | Echelon; Endopath |
| Medical Device Business Services, INC. | $187.84 | 2019 | |
| Abbvie INC. | $179.87 | 2019-2025 | |
| Davol INC. | $91.01 | 2021-2024 | Phasix Mesh |
| Astrazeneca Pharmaceuticals Lp | $68.49 | 2025 | Imfinzi |
| Tactile Systems Technology INC | $33.98 | 2022 | |
| Angiodynamics, INC. | $32.93 | 2023 | Angiodynamics |
| Nestle Healthcare Nutrition INC. | $22.37 | 2021 | |
| Integra Lifesciences Corporation | $19.68 | 2022 | |
| Becton, Dickinson and Company | $18.36 | 2024 | Hemosphere |
| Medtronic, INC. | $18.07 | 2022 | |
| Emmaus Medical, INC. | $13.87 | 2023 | Endari |
| Acell, INC. | $13.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.